More than two-thirds of chronic pain patients registered to legally access medical cannabis products substitute marijuana for prescription opioids, according to data published in The Journal of Headache and Pain Among those patients diagnosed specifically with headache/migraine, cannabis was frequently reported as a substitute for other medications – including opiates (43 percent), anti-depressants (39 percent), NSAIDS (21 percent), triptans (8 percent), and anti-convulsants (8 percent).
State regulators today certified a voter-initiated medical cannabis access measure for the 2018 ballot. Officials announced that proponents gathered nearly 154,000 validated initiative signatures from registered voters -- far exceeding the total necessary to place the measure before a statewide vote.
California NORML is once again teaming up with Americans for Safe Access to co-sponsor a Citizens Lobby Day in Sacramento next Monday, June 4, 2018! We'll kick things off by presenting the bills we'll be lobbying on, and arm you with fact sheets and tips on talking to your representatives most effectively.